- Cannabis Sector: Expansion and Headwinds - Jul 16New retail entry in Florida and a military anti-cannabis warning create a mixed start to the day for cannabis investors. Read what to watch and which names matter today.
- Cannabis Sector Wrap — Jul 15A mixed day in cannabis: an employee buyout, an uplisting push, and uneven regulatory news from states and abroad. Read what moved the sector and what you should watch next.
- Cannabis Sector: Missouri Momentum - Jul 15Missouri's cannabis market is expanding rapidly, with local operators scaling and retail demand rising. Read what that means for public cannabis names, ETFs, and near-term catalysts.
- Cannabis Sector Faces Regulatory Tests - Jul 14Ballot defeats in Idaho and a repeal qualifying in Massachusetts put regulatory risk front and center today. Corporate moves like Ascend's uplisting push and favorable court rulings offer counterpoints, but headwinds dominate.
- Cannabis Policy Momentum, FDA Psychedelics - Jul 14Federal and state policy moves are accelerating after the FDA released new psychedelic guidance and Congress advanced a key hospital drug-testing bill. Read how these developments could affect cannabis and psychedelic names today.
- Cannabis Sector Mixed Signals - Jul 13 WrapCuraleaf scored a regulatory win in Spain even as Pennsylvania dropped adult-use legalization from its budget. Federal and state policy moves created a mixed bag of opportunities and risks for cannabis investors today.
- Cannabis Policy Momentum Spurs Interest - Jul 13Policy shifts in Minnesota and a 4th Circuit judge's comments on marijuana and guns are reshaping legal risk and market opportunity in cannabis and adjacent psychedelics. Read what this means for your watchlist and near-term catalysts.
- Cannabis Sector Sees Policy Momentum - Jul 12Regulatory momentum showed up over the weekend as Minnesota pushes toward a psilocybin access program and a federal judge questioned the link between marijuana and gun rights. Heading into Monday, investors will watch state implementation timelines and pending court cases for clues on broader legal risk.
- Cannabis Morning Briefing - Jul 12Legal, medical, and local policy moves are reshaping the cannabis landscape heading into the long weekend. Read what investors should watch after a week of court signals, a clinical study, enforcement action, and San Francisco’s lounge proposal.
- Cannabis Sector Wrap - Jul 11Legal shifts, enforcement actions and local policy moves left mixed signals for cannabis investors. Read a concise wrap of the key rulings, regulatory risks, and local approvals heading into Jul 13.
- Cannabis Sector: Mixed Signals Ahead - Jul 11Policy headwinds and enforcement action are counterbalanced by medical-study support and retail expansion. Read a concise guide to what happened over the weekend and what you should watch.
- Cannabis Sector: Mixed Policy and Culture News - Jul 10Today’s cannabis headlines mixed consumer and cultural wins with regulatory pressure. Retail expansion and positive medical data sat alongside enforcement seizures and renewed calls for a hemp THC ban.
- Cannabis Sector Faces Ballot Headwinds - Jul 10An anti-cannabis measure qualified for the Massachusetts ballot, reviving policy risk for state markets and multi-state operators. Regulatory noise from several states keeps volatility high.
- Cannabis Sector Mixed Signals - Jul 9 WrapA Massachusetts rollback qualified for the November ballot while national momentum for medical acceptance and state-level legalization continued. Regulators, voters, and investors face competing signals ahead of November.
- Cannabis Outlook Mixed on Rescheduling, Jul 9A new poll shows most cannabis consumers don't expect full federal rescheduling this year, while state-level legal disputes and supportive research keep the story complex. Read what you should watch and which stocks investors track today.
- Cannabis Sector Sees Policy Momentum - Jul 8Today brought mixed but mostly positive signals for cannabis: banking groups lobbied Congress, gubernatorial candidates backed legalization, and new research showed social benefits. You’ll want to watch SAFE Banking progress and state-level pushback tomorrow.
- Cannabis Rules Clarified by Feds - Jul 8Federal guidance on cannabis scales landed in a Marijuana Moment newsletter today, alongside state implementation updates and a poll on THC drinks. Read what this means for operators, regulators, and the stocks you follow.
- Cannabis Sector Mixed Signals - Jul 7Illinois moved to expand retail access while Oregon proposed steep fees for psilocybin firms, creating a mixed day for the cannabis space. Regulatory updates, labor wins, and standardization efforts set a busy near-term calendar for investors.
- Cannabis Sector Eyes Banking-Backed Bill Push - Jul 7A banking trade group urged Congress to pass a federal cannabis banking bill, a development that could ease payment and banking access for the industry. Policy shifts plus state-level labor and medical society moves keep regulatory momentum in focus for investors.
- Cannabis Sector: Policy Pushes and New Limits - Jul 6Today brought a policy push for banking access, state regulatory approvals, and new product limits that create a mixed bag for cannabis stocks and operators. Read what matters for your positions and what to watch next.
- Cannabis Sector Faces State Regs Headwinds - Jul 6State-level bills in Virginia, North Carolina and Tennessee opened a fresh wave of regulatory risk for the cannabis and hemp markets. Today’s brief explains what changed, which firms are most exposed, and what you should watch next.
- Cannabis Policy Headwinds Intensify - Jul 5State-level restrictions from Virginia to North Carolina and a Tennessee hemp ban are creating regulatory uncertainty for growers and retailers. Heading into the long weekend, the sector faces near-term legal and market risk.
- Cannabis Sector: Rescheduling Momentum and Risks - Jul 5Federal momentum toward rescheduling cannabis to Schedule III clashes with state restrictions and fresh health studies. Heading into the July 6 open, investors should weigh policy progress against regulatory and safety headwinds.
- Cannabis Sector Mixed Signals - Jul 4 WrapDEA backing for Schedule III and Georgia's medical expansion point to policy gains, while North Carolina limits and a large teen mental-health study raise fresh risks. Read how these developments affect the sector heading into Jul 6.
- Cannabis Sector: Rescheduling Momentum - Jul 4Federal momentum toward moving cannabis to Schedule III and state-level ballot activity are the biggest forces heading into the long weekend. You should watch the DEA process, Idaho ballot review, and safety-related regulatory backlash.
- Cannabis Sector Sees Regulatory Push, Risks - Jul 3DEA support for moving cannabis to Schedule III and state ballot activity pushed reform back into focus, but transportation warnings and a major teen mental health study add caution. Heading into the long weekend, regulatory risk and state-level catalysts will dominate headlines next week.
- Cannabis Policy Momentum Builds - Jul 3The DOJ publicly criticized vested interests opposing cannabis rescheduling, a development that strengthens federal policy momentum. Analysts and investors will be watching regulatory signals and product research as markets are closed for the holiday.
- Cannabis Momentum Builds on Rescheduling Push - Jul 2Federal and state policy moves kept cannabis in focus on Jul 2, as the DOJ defended rescheduling and Rhode Island and Illinois cleared hurdles for expanded market access. Read what moved the sector and what you should watch next.
- Cannabis Retail Shifts to Experience - Jul 2Two High Times reports show dispensaries and consumer brands doubling down on hospitality and community marketing. Today you'll see why foot traffic, basket size, and loyalty matter more than ever.
- Cannabis Sector Mixed Signals - Jul 1 WrapFederal rescheduling hearings grabbed headlines while state-level moves produced both wins and setbacks. Read what happened today, how markets reacted, and what you should watch next.
- Cannabis Sector Eyes UK Legalization Momentum - Jul 1A High Times op-ed urges the next UK prime minister to legalize cannabis and fund teen mental health, renewing hopes for regulatory reform. What could this mean for market access and U.S. cannabis investors?
- Cannabis Sector Momentum — Jun 30 WrapToday’s Cannabis wrap covers a NYSE uplisting, a strong consumer poll favoring THC drinks, and grassroots market activity in New York. Read what moved the sector and what you should watch next.
- Cannabis Sector Eyes Rescheduling Momentum - Jun 30DEA testimony highlighted cannabis's medical benefits and relative safety, and bipartisan lawmakers signaled resistance to blocking rescheduling. Here’s what you need to know and watch today.
- Cannabis Sector: Rescheduling Momentum, State Wins & Risks - Jun 29Federal rescheduling hearings and Virginia's legalization advance the narrative for cannabis, but a corporate lawsuit, labor strikes, and state ballot snags temper enthusiasm. Read what's moving markets and what to watch tomorrow.
- Cannabis Policy Momentum and Market Signals - Jun 29Missouri opens a lottery window for 77 microbusiness cannabis licenses and Virginia leaves legalization language intact, keeping expansion on track. Continued hemp THC sales in South Carolina and cultural stories on product innovation add to sector momentum.
- Cannabis Wrap: Licenses, Laws & Signals - Jun 28Missouri opens a July lottery for 77 microbusiness marijuana licenses, Virginia leaves legalization language intact, and South Carolina keeps THC hemp products legal. Read what this means heading into the week.
- Cannabis Sector Roundup - Jun 28Policy friction and cultural trends defined the weekend. Key state-level decisions, federal rescheduling attention, and product innovation set the agenda for Monday as markets reopen. Read what you need to watch.
- Cannabis Sector Wrap - Jun 27Policy moves in Virginia and Washington, federal rescheduling momentum, and continued hemp THC access in South Carolina left mixed signals for the cannabis sector heading into the long weekend. Read what to watch next and how these developments tie to ETFs and key names.
- Cannabis Sector Eyes DEA Rescheduling - Jun 27Federal rescheduling hearings and a push for livestream access are putting cannabis policy back in the spotlight, while state programs and culture-driven coverage boost normalization. Read what you need to know heading into the long weekend.
- Cannabis Sector Wrap Jun 26Federal rescheduling hearings and calls for livestreaming dominated cannabis headlines today, while the Trump administration urged Congress to regulate hemp or delay a crackdown. State-level moves on psychedelics and tourist education add to near-term catalysts for the sector.
- Cannabis Policy Moves Hit Markets - Jun 26Congress filed cannabis banking legislation today while federal and state regulators press on enforcement issues. You should watch how lawmakers, the DEA, and state actions shape liquidity and risk for names like $MSOS and $TLRY.
- Cannabis Sector Mixed Signals - Jun 25 WrapRegulatory pressure from the DEA over synthetic HHC and a stacked rescheduling hearing weighed on the sector, while a bipartisan SAFE banking bill and state advocacy offered counterbalance. Read what matters for traders and what to watch next.
- Cannabis Sector: Jobs Slip, Licensing Opens - Jun 25U.S. cannabis jobs fell 2.7% and sales declined 3.3% in 2025, but Missouri's new microbusiness license round and higher cannabis use among younger patients keep the sector active. Read what you should watch today.
- Cannabis Sector Sees Policy Wins and Retail Growth - Jun 24Today brought a string of state-level wins and retail expansion for cannabis, with Virginia moving toward adult-use sales and a California brand hitting 300 dispensaries. Federal rescheduling debate remains a near-term catalyst for the sector.
- Cannabis Brands Lean Into Culture with DJ Screw Pack - Jun 24Slapwoods launched a limited DJ Screw collaboration that spotlights cultural marketing in cannabis. Read what that means for brand-led growth, sector sentiment, and the tickers to monitor today.
- Cannabis Policy, Research Drive Momentum - Jun 23Today’s headlines pushed cannabis into the policy and public-health spotlight, with a fight over livestreaming of the DEA rescheduling hearing, new clinical data from Minnesota, and Alaska sealing cannabis records. Read what moved the sector and what you should watch next.
- Cannabis Market: Uplists and Regulation - Jun 23New York moves to block illicit cannabis from the regulated market, Vermont expands possession limits and interstate language, and Glass House files to uplist to the NYSE. Here’s what you need to know for today.
- Cannabis Policy Momentum and Risks - Jun 22Virginia advances recreational sales and Connecticut signs the state’s first tribal cannabis compact, while a Minnesota testing lab shuts down and political attacks surface. Mixed policy wins and regulatory risks set the tone for the week.
- Cannabis Policy Shifts and State Moves - Jun 22Vermont approved a major cannabis reform with interstate commerce and doubled possession limits while North Carolina momentum stalls. Read what these state moves mean for multistate operators and your watchlist.
- Cannabis Sector: Policy Shifts and Local Wins - Jun 21Vermont approved a broad cannabis reform bill including interstate commerce while North Carolina’s ballot push looks unlikely to advance. Read what these developments mean for operators and ETFs as markets reopen Monday.